跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LAMICTAL 200 MG COMPRIMIDOS MASTICABLES/DISPERSABLES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LAMICTAL 200 MG COMPRIMIDOS MASTICABLES/DISPERSABLES
Approved
STANDARD
LAMICTAL 200 MG COMPRIMIDOS MASTICABLES/DISPERSABLES
Laboratoire Glaxosmithkline
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 27, 2024
Approval ID
790c8a4f058d7dd4
Company
Laboratoire Glaxosmithkline
Type
Standard
Approval Details
Approval Id
790c8a4f058d7dd4
Drug Cima Aemps Name
LAMICTAL 200 MG COMPRIMIDOS MASTICABLES/DISPERSABLES
Register Number
3400930225189
Holder Company Name
Laboratoire Glaxosmithkline
Marketing Company Name
Euromed Pharma Spain S.L.
Holder Company Detail Path
/organization/laboratoire-glaxosmithkline
Authorization Date
2024-05-27
Dosage Form
COMPRIMIDO MASTICABLE Y DISPERSABLE
Dose
200 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
Yes
Company Name
Laboratoire Glaxosmithkline
Company Detail Path
/organization/laboratoire-glaxosmithkline
Company Information
Pharmaceutical Company Name
LABORATOIRE GLAXOSMITHKLINE
Country Name
France
City Name
rueil-malmaison,ile de france,country_fr
Address
23 RUE FRANCOIS JACOB
Active Ingredients
LAMOTRIGINA
200 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 27, 2024
Approval ID
790c8a4f058d7dd4
Type
Standard
Back to CIMA-AEMPS Approvals